济南男性前列腺肥大(济南性工能不行怎么办) (今日更新中)

After three days of speeches from the Democratic Party's top brass, Thursday marks the convention's highlight — Joe Biden's acceptance speech for the party nomination.Biden will deliver his acceptance speech from his home state of Delaware — a speech he's been waiting to give for more than 30 years. Biden first ran for president in the 1988 cycle and ran again in 2008 — which eventually landed him the role of Vice President.While many national polls show Biden holding a double-digit lead over Trump, but Biden has mostly shied away from the spotlight during the general election cycle, preferring to hold virtual campaign events from his home amid the pandemic. With an audience of millions tuning in, Biden will face the most high-profile test of his campaign to date.Biden will also be competing for airtime against his general election opponent, President Donald Trump, who scheduled an interview on Fox News during the 9 p.m. hour — just as the DNC is getting underway for the evening.Several of Biden's opponents in the 2020 Democratic primaries will deliver speeches ahead of him this evening, including former South Bend Mayor Pete Buttigieg, former New York Mayor Michael Bloomberg and Sen. Corey Booker (D-New Jersey).Thursday's program will also feature rising female stars in the party, like Sen. Tammy Duckworth (D-Illinois) and Atlanta Mayor Keisha Lance Bottoms.John Legend, Common and The Chicks (formerly known as the Dixie Chicks) will offer musical performances during Thursday's event.See a full schedule of Thursday's speeches and performances below.“This Time Next Year”A "collection of everyday Americans and prominent leaders" describe where they want the country to be a year from now.Remarks by 2020 presidential candidate Andrew YangIntroductionActress Julia-Louis DreyfusPledge of AllegianceLed by Cedric Richmond, Jr., son of Rep. Cedric Richmond (D-Louisiana)National AnthemPerformed by The Chicks (Natalie Maines, Martie Erwin Maguire, and Emily Strayer)InvocationDelivered by Sister Simone CampbellRemarksSen. Chris Coons (D-Delaware)Atlanta Mayor Keisha Lance BottomsA Tribute to John LewisDirected by Dawn PorterMusical performanceJohn Legend and CommonRemarksJon Meacham, writer and authorRep. Deb Halaand (D-New Mexico)California Sec. of State Alex PadillaMichigan Sec. of State Jocelyn BensonSen. Cory Booker (D-New Jersey)“You Built America”:A Conversation on the Economy with Joe BidenRemarksFormer U.S. Surgeon General Dr. Vivek MurthySen. Tammy Baldwin (D-Wisconsin)The Biden Plan: Military FamiliesJoe and Jill Biden show commitment to military families in video.RemarksSen. Tammy Duckworth (D-Illinois)Tribute to Beau BidenRemarksFormer South Bend Mayor Pete Buttigieg“United We Stand”A video that explores Biden's political opponents in the 2020 Democratic primariesRemarksFormer New York Mayor Michael BloombergThe Biden GrandchildrenVideo focused on Bidewn's family lifeRemarks by Biden's children, Ashley and HunterIntroduction of Joe BidenJoe Biden Acceptance Speech 3026

Airport security checkpoints can be among the worst things about air travel. Most of us would like to have the TSA Pre-Check so we can skip the long lines and the wait, but the cost to have it processed steers us away from this travel perk.If you have a trip coming up this year, there is some good news. There's a way to get a free TSA Pre-Check membership.Right now, there are at least 12 credit cards and 5 loyalty programs that will let you get a TSA Pre-Check membership for free.The credit cards include certain American Express cards, Bank of America premium rewards, Chase Sapphire and Expedia Voyager card from Citi.The loyalty programs include Marriott rewards, United Mileage Plus and Club Carlson. We found, while many of the credit cards cover the TSA Pre-Check fee outright, the loyalty programs pay for it with points.You also need to consider if there's an annual fee for the credit card and if the tradeoff is worth it.Of course anytime you sign up for a credit card and or loyalty program you'll want to read the fine print, but it could be worth your while to check out your options to save some cash, and some time, when you travel.  1199

All Coca-Cola needed to do to rejuvenate Diet Coke was add some Feisty Cherry, Twisted Mango, Ginger Lime and Zesty Blood Orange. In skinny cans.Diet Coke posted sales volume growth in North America during the first quarter, thanks in large part to those four new flavors. Coca-Cola said it was the first time Diet Coke's volume had risen in the United States and Canada since late 2010.The new Diet Coke flavors, introduced in January, were "bold enough and interesting enough" to attract more Millennials and people who prefer flavored sparkling water to soda, CEO James Quincey said.The long slump in Diet Coke sales is partly because of the popularity of LaCroix, a sparkling water brand owned by National Beverage. Coca-Cola is looking to gain ground in that market: It bought the rights to sell the Mexican mineral water Topo Chico in the United States last October.But consumers, especially Millennials, have also turned away from diet soda in favor of healthier options.Quincey, who took over as CEO of Coke last May from longtime chief Muhtar Kent, said in February that Coke needs to shake things up if it wants to attract younger customers. The new Diet Coke flavors are an example of that."We've got to experiment, which means learning from the tech industry, the 1.0, the 2.0, the 3.0. Don't make it perfect, get something out there, learn, and make it better," Quincey told Harlow.Coke has been busy with other newish products. It rebranded Coke Zero as Coke Zero Sugar — and that subtle change also seems to be working. Sales rose at a double-digit pace in the quarter. Tea and coffee sales were up 5%, too.Wall Street wasn't impressed with Coke's results, though. Even though overall sales and profits topped forecasts, the stock fell nearly 2% on Tuesday. Shares are down 6% this year.Pablo Zuanic, an analyst at Susquehanna Financial Group, noted that lower pricing in North America may have helped boost sales. And Wall Street may not be pleased with that. He said he expected the stock to "tread water" as a result.For the past five years, Coke's stock has lagged top rival Pepsi, which also owns a thriving snack food business, and Dr Pepper Snapple, which recently agreed to sell itself to the coffee giant Keurig Green Mountain. 2259

Actor Jeff Bridges gave an update on his battle against lymphoma this week, showing off a bald head and a new puppy.The 71-year-old announced in October he had been diagnosed with lymphoma, and said at the time his prognosis was good and he promised to keep fans updated.In an Instagram post Monday, Bridges said he was “feeling good” while sitting outside holding his new puppy.“Here’s the latest:? Feeling good? Shaved my head? Got a puppy - Monty? Had a Birthday - 71, man”https://www.instagram.com/p/CIygGEBAxg8/Bridges posted a longer message on his personal site, which included a plea to help support musicians who are struggling to get gigs and make ends meet during the pandemic.He also directed fans to No Kid Hungry, saying “the health of our children can serve as a compass, letting us know if we’re on course or not - we’re off course.”In an earlier update on his treatment, the day before Halloween, Bridges shared an image of himself getting chemotherapy. 978

After struggling to ramp up coronavirus testing, the U.S. can now screen several million people daily, thanks to a growing supply of rapid tests. But the boom comes with a new challenge: keeping track of the results.All U.S. testing sites are legally required to report their results, positive and negative, to public health agencies. But state health officials say many rapid tests are going unreported, which means some new COVID-19 infections may not be counted.And the situation could get worse, experts say. The federal government is shipping more than 100 million of the newest rapid tests to states for use in public schools, assisted living centers and other new testing sites.“Schools certainly don’t have the capacity to report these tests,” said Dr. Jeffrey Engel of the Council of State and Territorial Epidemiologists. “If it’s done at all it’s likely going to be paper-based, very slow and incomplete.”Early in the outbreak, nearly all U.S. testing relied on genetic tests that could only be developed at high-tech laboratories. Even under the best circumstances, people had to wait about two to three days to get results. Experts pushed for more “point-of-care” rapid testing that could be done in doctors offices, clinics and other sites to quickly find people who are infected, get them into quarantine and stop the spread.Beginning in the summer, cheaper, 15-minute tests — which detect viral proteins called antigens on a nasal swab — became available. The first versions still needed to be processed using portable readers. The millions of new tests from Abbott Laboratories now going out to states are even easier to use: they’re about the size of a credit card and can be developed with a few drops of chemical solution.Federal health officials say about half of the nation’s daily testing capacity now consists of rapid tests.Large hospitals and laboratories electronically feed their results to state health departments, but there is no standardized way to report the rapid tests that are often done elsewhere. And state officials have often been unable to track where these tests are being shipped and whether results are being reported.In Minnesota, officials created a special team to try and get more testing data from nursing homes, schools and other newer testing sites, only to be deluged by faxes and paper files.“It’s definitely a challenge because now we have to do many more things manually than we were with electronic reporting,” said Kristen Ehresmann, of the Minnesota Department of Health.Even before Abbott’s newest BinaxNOW rapid tests hit the market last month, undercounting was a concern.Competitors Quidel and Becton Dickinson have together shipped well over 35 million of their own quick tests since June. But that massive influx of tests hasn’t showed up in national testing numbers, which have mostly ranged between 750,000 and 950,000 daily tests for months.Besides tallying new cases, COVID-19 testing numbers are used to calculate a key metric on the outbreak: the percentage of tests positive for COVID-19. The World Health Organization recommends countries test enough people to drive their percent of positives below 5%. And the U.S. has mostly been hovering around or below that rate since mid-September, a point that President Donald Trump and his top aides have touted to argue that the nation has turned the corner on the outbreak. The figure is down from a peak of 22% in April.But some disease-tracking specialists are skeptical. Engel said his group’s members think they aren’t getting all the results.“So it may be a false conclusion,” he said.One of the challenges to an accurate count: States have wildly different approaches. Some states lump all types of tests together in one report, some don’t tabulate the quick antigen tests at all and others don’t publicize their system. Because antigen tests are more prone to false negatives and sometimes require retesting, most health experts say they should be recorded and analyzed separately. But currently the vast majority of states do not do that and post the results online.The federal government is allocating the tests to states based on their population, rather than helping them develop a strategy based on the size and severity of their outbreaks.“That’s just lazy” said Dr. Michael Mina of Harvard University. “Most states won’t have the expertise to figure out how to use these most appropriately.”Instead, Mina said the federal government should direct the limited test supplies to key hot spots around the country, driving down infections in the hardest-hit communities. Keeping tighter control would also ensure test results are quickly reported.Johns Hopkins University researcher Gigi Gronvall agrees health officials need to carefully consider where and when to deploy the tests. Eventually, methods for tracking the tests will catch up, she said.“I think having the tools to determine if someone is infectious is a higher priority,” she said.___AP data journalist Nicky Forster contributed to this story___Follow Matthew Perrone on Twitter: @AP_FDAwriter___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 5285

来源：资阳报